In conversation with Will Hind of Alpharmaxim: applying behavioural science in biopharma
Note this is a video recording of an online meeting conducted using the Zoom.us platform. Inevitably such recordings suffer a little in terms of their production values because of the internet connectivity and quality of webcams. Despite that, they allow us to provide valuable insights into our business and we can involve a wider range of speakers who can participate from the comfort of their own desks, wherever in the world they are. The NPTV Unscripted conversations are led by Peter Llewellyn of NetworkPharma.tv and are intended as informal conversations with folks, from across the global industry, who we think have something interesting to share. Let's see what we can learn! In this episode, Peter is joined by Will Hind, founder and CEO of Alpharmaxim, a healthcare communications agency. Will is a passionate advocate for the practical application of behavioural science principles to strategic comms programmes. Last week, Will and his team published a white paper exploring hidden barriers to adoption of new treatments in Parkinson's, which gives us the excuse to learn more about how this approach can work in practice. Further information: White Paper: Parkinson’s: Beyond the hidden barriers to adoption of new treatments at https://alpharmaxim.com/wp-content/up... Behavioural analysis of factors influencing prescribing for neurodegenerative diseases: A rapid review | PLOS One at https://journals.plos.org/plosone/art... Can behavioural science be used to understand factors that influence the prescription choice for Parkinson’s disease? A pan-European focus group study of clinicians’ prescribing practice | BMJ Open at https://bmjopen.bmj.com/content/15/2/... LinkedIn newsletter: Behaviour Changing Comms from Alpharmaxim at / 7393995423251861505 The Behaviour Change Wheel, A Guide To Designing Interventions by Susan Michie, Lou Atkins & Robert West at https://www.behaviourchangewheel.com/ Thinking, Fast and Slow by Daniel Kahneman at https://www.amazon.co.uk/Thinking-Fas... Recorded 26 November 2025 as an NPTV Unscripted conversation. Produced by NetworkPharma.tv Peter’s LinkedIn page is at / networkpharma Will’s LinkedIn page is at / williamhind Find out more about Alpharmaxim at https://alpharmaxim.com/ = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = We are building a library of free recordings, like this one, for a global pharmaceutical industry audience at NetworkPharma.tv and we’d welcome your suggestions for new topics and speakers. For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like.

In conversation with Rick Flemming of Aspire Scientific: award-winning MedComms business leader

In conversation with Eugene Pozniak, Founder and Programme Director of European CME Forum

Improving Dementia Care for People with Intellectual Disabilities - 06/02/2026

The AI Safety Expert: These Are The Only 5 Jobs That Will Remain In 2030! - Dr. Roman Yampolskiy

In conversation with Lawrence Sherman of Meducate Global: delivering effective medical education

AI for Small Business how to get more done without working more hours

The French Do Not Care About Work

Ex-Google Recruiter Explains Why "Lying" Gets You Hired

Wie Tech-Milliardär Peter Thiel die Apokalypse verhindern will | 3sat kulturzeit

Fatty Liver Expert: The Toxic Ingredient Silently Filling Your Liver With Fat - Dr David Unwin

I Hacked This Temu Router. What I Found Should Be Illegal.

Wie werden Biopharmazeutika in Zellkulturen produziert?

Trump Gets Booed & Falls Asleep During NBA Finals, Claims War is Almost Over & Goodbye Spencer Pratt

Conan O’Brien Delivers the Commencement Address | Harvard Commencement 2026

WARNING: The Hidden Dangers of Titanium Dental Implants!

Karim Toubba, LastPass | The Cybersecurity Bridge

Anthropic CEO on Safety, Job Displacement and Anthropic's $350B Valuation | WSJ

In conversation with Dominic Marchant, Chair of the UK’s PM Society

Harvard Professor Explains The Rules of Writing — Steven Pinker

